Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial to Evaluate the Effectiveness of Angular Stable Locking System for Intramedullary Nails (ASLS) in Patients With Distal Tibial Fractures Treated With Expert Tibial Nails (ETN)
This study is not yet open for participant recruitment.
Study NCT00875992   Information provided by AO Clinical Investigation and Documentation
First Received: April 3, 2009   No Changes Posted

April 3, 2009
April 3, 2009
June 2009
July 2011   (final data collection date for primary outcome measure)
Time to pain free full weight bearing [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Amount of partial weight bearing [ Time Frame: Up to achievement of primary outcome ] [ Designated as safety issue: No ]
Same as current
 
Trial to Evaluate the Effectiveness of Angular Stable Locking System for Intramedullary Nails (ASLS) in Patients With Distal Tibial Fractures Treated With Expert Tibial Nails (ETN)
A Randomized Controlled Trial to Evaluate the Effectiveness of Angular Stable Locking System (ASLS) in Patients With Distal Tibial Fractures Treated With Expert Tibial Nails (ETN)

In many cases, the existing locking bolts and screws in intramedullary nails do not provide sufficient stability. The play between screw and nail can result in loss of reduction and the instability due to the interfragmentary movement can result in malunions or nonunions. Therefore, an Angular Stable Locking System for Intramedullary Nails (ASLS) was developed to enhance axial and angular fracture stability. ASLS provides angular-stable fixation between nails and screws with resorbable sleeves used as dowels in the nail locking holes. Preliminary results of a pre-study show a trend towards reduced time to pain-free full weight bearing in patients being treated with ASLS. This hypothesis will be tested in the present randomized controlled study.

 
 
Interventional
Allocation:  Randomized
Endpoint Classification:  Efficacy Study
Intervention Model:  Parallel Assignment
Masking:  Single Blind (Subject)
Primary Purpose:  Treatment
Tibial Fractures
  • Device: ETN with ASLS
    Angle stable locking of ETN using ASLS
  • Device: ETN locked with conventional locking bolts
    Conventional surgical procedure
  • ETN with ASLS: Experimental
    Angle stable locking of the Expert Tibial Nail using ASLS
    Intervention: Device: ETN with ASLS
  • ETN with conventional locking: Active Comparator
    Conventional locking of the Expert Tibial Nail using conventional locking bolts
    Intervention: Device: ETN locked with conventional locking bolts
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Not yet recruiting
140
November 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • The patient is ≥ 18 years old
  • The patient suffers from an acute distal third tibial fracture classified as:

AO 42 A1-A3, AO 42 B1-B3, AO 42 C1-C3, AO 43 A1-A3

  • The fracture is fixed with an Expert Tibia Nail (ETN)
  • The patient was able to walk without walking aid prior to the accident
  • The patient is able to understand and read local language at elementary level
  • The patient is willing and able to give written informed consent to participate in the study according to the CIP

Exclusion Criteria:

  • The patient is legally incompetent
  • Preexistent malunion or nonunion of the fracture under investigation
  • Osteotomies
  • The patient suffers from additional fractures of the lower extremities (Exception: ipsilateral fibular fracture)
  • The patient suffers from a pathologic fracture
  • The patient suffers from active malignancy
  • The patient is pregnant, breast feeding or planning to get pregnant during the study period
  • The patient suffers from a life-threatening condition
  • The patient is affected by drug or alcohol abuse
  • The patient has participated in any device related clinical trial affecting the lower extremities within the previous month
  • The patient has participated in any drug related clinical trial affecting bone healing within the previous month
Both
18 Years and older
No
Contact: Denise Schmid +41 (0) 44 200 24 77 Denise.Schmid@aofoundation.org
Contact: Peter Langer, PhD +41 (0) 44 200 24 68 Peter.Langer@aofoundation.org
 
 
NCT00875992
Prof. Dr. med. Dankward Höntzsch, BG Unfallklinik Tübingen
ASLS RCT 09
AO Clinical Investigation and Documentation
Synthes Inc.
Principal Investigator: Dankward Hoentzsch, MD BG Unfallklinik Tübingen, 72076 Tübingen, Germany
AO Clinical Investigation and Documentation
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP